Institutional owners may ignore Dyne Therapeutics, Inc.'s (NASDAQ:DYN) recent US$56m market cap decline as longer-term profits stay in the green

Key Insights Institutions' substantial holdings in Dyne Therapeutics implies that they have significant influence over...

Related Keywords

,Dyne Therapeutics Inc ,Dyne Therapeutic ,Dyne Therapeutics ,Institutional Investors ,Shareholders ,Company ,Nstitutions ,